|
|
Medical News: Livestrong(R) Global Cancer Campaign Announces Groundbreaking New European Commitments To Cancer
|
Medical News: What Is Colorectal Cancer? What Causes Colorectal Cancer?
|
LIVESTRONG(R) Global Cancer Campaign Announces Groundbreaking New European Commitments to Cancer Control
|
Minot State University Receives CEO Cancer Gold StandardTM Accreditation
|
Tunnell Cancer Center earns award
|
[Breast Cancer] Menstrual Cycle and Surgical Treatment of Breast Cancer: Findings From the NCCTG N9431 Study
|
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
|
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
|
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
|
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
|
Millennium Pharmaceuticals Receives CEO Cancer Gold Standard Accreditation
|
Millennium Pharmaceuticals Receives CEO Cancer Gold StandardTM Accreditation
|
Journal reports outline H. Lee Moffitt Cancer Center, Tampa, U.S., research
|
Medivation Announces Treatment of First Patient in Phase 1-2 Clinical Trial of MDV3100 in Hormone-Refractory Prostate Cancer
|
Genetic Tests Identify Cancer Risks: UNM program looks for mutations in genes, leading some people to have pre-emptive surgery
|
CTRC Enrolls First Patients in Phase II Study; Living Virus Destroys Cancer Cells in Sarcoma Patients
|
U-M, Israeli scientists report major advance in search for genes associated with colon cancer
|
Reports from the United States, the United Kingdom and Italy highlight recent research in ovarian cancer
|
Genentech officials describe the recent activities
|
Researchers' data from University of Texas, U.S., highlight new research
|
